![Amy Finan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amy Finan
Amministratore Delegato presso Albert B. Sabin Vaccine Institute, Inc.
Posizioni attive di Amy Finan
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | 19/02/2014 | - |
Vendite & Marketing | 01/10/2004 | 19/02/2014 | |
Albert B. Sabin Vaccine Institute, Inc.
![]() Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Direttore/Membro del Consiglio | 18/04/2016 | - |
Amministratore Delegato | 18/04/2016 | - |
Storia della carriera di Amy Finan
Precedenti posizioni note di Amy Finan
Società | Posizione | Inizio | Fine |
---|---|---|---|
CASI Pharmaceuticals, Inc. /Old/
![]() CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Public Communications Contact | 01/01/2001 | - |
National Association For Biomedical Research | Consigliere Generale | 01/01/1987 | - |
Formazione di Amy Finan
Trinity College (District of Columbia) | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Corporate Officer/Principal | 1 |
Sales & Marketing | 1 |
Undergraduate Degree | 1 |
Settori
Commercial Services | 3 |
Consumer Services | 2 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
National Association For Biomedical Research | Finance |
CASI Pharmaceuticals, Inc. /Old/
![]() CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Albert B. Sabin Vaccine Institute, Inc.
![]() Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
- Borsa valori
- Insiders
- Amy Finan
- Esperienza